ArticleFrontiers in pharmacology2024

Risk of potential hepatotoxicity from pirfenidone or nintedanib in patients with idiopathic pulmonary fibrosis: results of a retrospective analysis of a large insurance database in Taiwan.

Kuang-Ming Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.